Shandong Weigao Group Medical Polymer Company Limited (FRA:UK2)

Market Cap	1.70B -51.8%
Revenue (ttm)	1.63B +2.3%
Net Income	196.32M -22.0%
EPS	0.04 -22.2%
Shares Out	n/a
PE Ratio	8.64
Forward PE	7.79
Dividend	0.02 (5.49%)
Ex-Dividend Date	Jun 2, 2026

Volume	n/a
Open	0.3512
Previous Close	0.3477
Day's Range	0.3512 - 0.3512
52-Week Range	0.3264 - 0.7650
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About FRA:UK2

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutio...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1988
• Employees: 13,307
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UK2

Financial Performance

In 2025, FRA:UK2's revenue was 13.39 billion, an increase of 2.31% compared to the previous year's 13.09 billion. Earnings were 1.61 billion, a decrease of -21.99%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 28, 2026

Data Sources Report a data error